Hanover - Delayed Quote EUR

Aurora Cannabis Inc (21P.HA)

3.5600

+0.0100

+(0.28%)

At close: 5:25:30 PM GMT+1

Aurora Cannabis Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country's expanding patient base.

PR Newswire 7 days ago

ACB
Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2025 before the opening of markets that same day.

PR Newswire 8 days ago

ACB
Empowering the Next Generation: Aurora Announces German Internship Program

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the launch of an internship program at Aurora's leading EU-GMP facility in Leuna, Germany. In partnership with Erfurt University of Applied Sciences, students of the Horticultural Crop Production course will gain valuable hands-on experience on-site and deepen their understanding of medical cannabis cultivation. Aurora's investment in future industry leaders is one of

CNW Group 20 days ago

ACB
New York cannabis sales set for $1.5B surge in 2025

New York’s cannabis market is poised for major growth in 2025, with sales expected to hit $1.5 billion and the number of legal marijuana shops more than doubling. Dan Ahrens, AdvisorShares Pure US Cannabis ETF portfolio manager, joins Market Domination to discuss how current political delays and market volatility have affected cannabis stock. "We keep expecting federal reform, we keep getting promised federal reform, and when we had this past election, these cannabis stocks took yet another hit because the investing public out there really thinks that the Republican Party is bad for cannabis," Ahrens explains. He notes the Democratic Party could have been good for cannabis but that "people in our space feel like we've just been gaslighted for the past four years by Democrats.” Ahrens still suggests 2025 could bring change, with cannabis potentially rescheduled as a Schedule III controlled substance, which would be a big positive for companies. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Josh Lynch

Yahoo Finance Video 22 days ago

TLRY

CGC

MJ
Why Is Aurora Cannabis (ACB) One of the Best CBD Stocks to Invest In Right Now?

We recently published a list of 7 Best CBD Stocks To Invest In Right Now. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against other best CBD stocks to invest in right now. An essential component of medical marijuana, CBD is the legal, non-psychoactive compound that […]

Insider Monkey 22 days ago

ACB
January 2025's Top Picks for Stocks Estimated Below Intrinsic Value

As global markets navigate mixed performances and economic uncertainties, investors are keenly assessing opportunities for value amid fluctuating indices and economic indicators. With the S&P 500 Index marking significant gains over the past two years despite recent contractions, identifying stocks trading below their intrinsic value becomes particularly appealing in this environment. In such a context, a good stock is one that demonstrates strong fundamentals and potential for growth, even...

Simply Wall St. 24 days ago

ACB

PBBGF
Is Aurora Cannabis Inc. (ACB) the Best Marijuana Stock to Buy According to Hedge Funds?

We recently compiled a list of the 10 Best Marijuana Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against the other marijuana stocks. The United States of America is the country that consumes the most weed in the world. As […]

Insider Monkey last month

ACB
Is There An Opportunity With Aurora Cannabis Inc.'s (TSE:ACB) 37% Undervaluation?

Key Insights Aurora Cannabis' estimated fair value is CA$9.65 based on 2 Stage Free Cash Flow to Equity Aurora...

Simply Wall St. last month

ACB
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and support services to pharmacies in Australia and will serve as a wholesaler for MedReleaf Australia's leading portfolio of products under the CraftPlant, Aurora, and IndiMed brands, furthering the mission to expand access for Aus

CNW Group last month

ACB
Why Aurora Cannabis (ACB) Is Among the Best Cannabis Stocks To Invest In?

We recently compiled a list of the 11 Best Cannabis Stocks To Invest In. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against the other best cannabis stocks to invest in. The history of cannabis cultivation in America dates back to the early colonists, who grew […]

Insider Monkey last month

ACB
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora's world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora's commitment to providing patients with ongoing access to superior product offerings on AuroraMedical.com.

CNW Group 2 months ago

ACB
Aurora Cannabis Expands Innovative Recreational Product Portfolio

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is excited to announce its latest lineup of innovations from Greybeard, San Rafael '71 and Tasty's brands. With a continued focus on premium, science-driven offerings, this expanded lineup represents Aurora's commitment to delivering exceptional high quality, cutting-edge and diverse options for Canadian cannabis consumers.

CNW Group 2 months ago

ACB
Aurora Cannabis Second Quarter 2025 Earnings: EPS: CA$0.05 (vs CA$0.048 in 2Q 2024)

Aurora Cannabis ( TSE:ACB ) Second Quarter 2025 Results Key Financial Results Revenue: CA$81.1m (up 28% from 2Q 2024...

Simply Wall St. 2 months ago

ACB
Aurora Cannabis Inc (ACB) Q2 2025 Earnings Call Highlights: Record Growth in Medical Cannabis ...

Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis sales, while maintaining a robust cash position with no debt.

GuruFocus.com 2 months ago

ACB
Aurora Cannabis (ACB) Q2 2025 Earnings Call Transcript

ACB earnings call for the period ending September 30, 2024.

Motley Fool 2 months ago

ACB
Aurora Cannabis Inc. (ACB) Beats Q2 Earnings and Revenue Estimates

Aurora Cannabis (ACB) delivered earnings and revenue surprises of 118.18% and 11.97%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

ACB
Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025.

PR Newswire 2 months ago

ACB
Election 2024: Harris, Trump agree on cannabis policy

The US presidential election is on the horizon. While Vice President Harris and former President Donald Trump differ on many issues, they share common ground on cannabis reform. Poseidon co-founder Emily Paxhia joins Market Domination Overtime to analyze this development. "I think it's finally showing how the electorate's will to see cannabis as a legal resource in the United States is finally reaching the lawmakers and at the highest level of the executive branch in this instance," she explains. Despite this political alignment, cannabis stocks have shown little movement. Paxhia attributes this to "a structural issue around being able to trade in the US" due to custody limitations. She suggests banking reform could resolve this barrier, potentially increasing investor access to cannabis stocks. For more insights on bipartisan support for cannabis reform and regulation, watch the full interview above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith

Yahoo Finance Video 2 months ago

ACB

CGC

CRON
GE HealthCare Technologies (GEHC) Tops Q3 Earnings Estimates

GE HealthCare (GEHC) delivered earnings and revenue surprises of 7.55% and 0.02%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

ACB
Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today announced today that it has scheduled a conference call to discuss the results for its second quarter 2025 on Wednesday, November 6, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the second quarter 2025 before the opening of markets that same day.

PR Newswire 3 months ago

ACB

Performance Overview

Return	21P.HA	S&P/TSX Composite index
YTD	-12.32%	+4.82%
1-Year	-6.07%	+21.74%
3-Year	-89.56%	+24.43%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Aurora Cannabis Inc (21P.HA)

Aurora Cannabis Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License

Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call

Empowering the Next Generation: Aurora Announces German Internship Program

New York cannabis sales set for $1.5B surge in 2025

Why Is Aurora Cannabis (ACB) One of the Best CBD Stocks to Invest In Right Now?

January 2025's Top Picks for Stocks Estimated Below Intrinsic Value

Is Aurora Cannabis Inc. (ACB) the Best Marijuana Stock to Buy According to Hedge Funds?

Is There An Opportunity With Aurora Cannabis Inc.'s (TSE:ACB) 37% Undervaluation?

Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect

Why Aurora Cannabis (ACB) Is Among the Best Cannabis Stocks To Invest In?

Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility

Aurora Cannabis Expands Innovative Recreational Product Portfolio

Aurora Cannabis Second Quarter 2025 Earnings: EPS: CA$0.05 (vs CA$0.048 in 2Q 2024)

Aurora Cannabis Inc (ACB) Q2 2025 Earnings Call Highlights: Record Growth in Medical Cannabis ...

Aurora Cannabis (ACB) Q2 2025 Earnings Call Transcript

Aurora Cannabis Inc. (ACB) Beats Q2 Earnings and Revenue Estimates

Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

Election 2024: Harris, Trump agree on cannabis policy

GE HealthCare Technologies (GEHC) Tops Q3 Earnings Estimates

Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call

Performance Overview